FeesSafety
Pluang+

Pliant Therapeutics names Craig Blanchette SVP of Research to boost RNAi drug delivery platform.

Market News
20 Oct 2026, 15:30 WIB
GlobeNewsWire
View Source
Bullish
Pliant Therapeutics names Craig Blanchette SVP of Research to boost RNAi drug delivery platform.

Pliant Therapeutics appointed Craig Blanchette, Ph.D., as Senior Vice President of Research (siRNA) to enhance its integrin-mediated RNAi drug delivery platform. Blanchette brings over 20 years of expertise in RNAi and oligonucleotide chemistry, previously leading RNAi programs at Switch Therapeutics and Genentech. His addition is expected to accelerate Pliant's development of targeted siRNA therapeutics for diseases with high unmet needs. The company also granted him stock options as part of his employment inducement under Nasdaq rules.

Pliant Therapeutics appointment news provides context for health sector trading. As of Oct 20, 2026 19:03 WIB, 81 of 150 health-sector US stocks on Pluang rose, 62 fell. Notable movers include CTXR at USD 0.45 (+5.19%), XRAY at USD 8.84 (+4.99%), and ENVB at USD 1.34 (-4.96%).

More News

Bristol Myers Squibb outgrows Novo Nordisk in 2027 with rising revenue and net income despite pricing pressures.

Bristol Myers Squibb outgrows Novo Nordisk in 2027 with rising revenue and net income despite pricing pressures.

Bristol Myers Squibb is expected to grow revenue by 3% and net income by over 40% in 2027, benefiting from new growth brands and a strong pipeline despite challenges like pricing pressures and patent expirations. Novo Nordisk, while dominant in obesi...

Market News
Bullish
1 hour ago
Adding ETFs with overlapping holdings can reduce diversification benefits in your portfolio.

Adding ETFs with overlapping holdings can reduce diversification benefits in your portfolio.

Investors often buy ETFs for instant diversification, but adding multiple ETFs with similar holdings, like iShares Core S&P 500 ETF (IVV) and Vanguard S&P 500 ETF (VOO), may lead to significant overlap rather than true diversification. Both funds tra...

Market News
Neutral
1 hour ago
Nasdaq enters correction amid rapid sell-off; Nvidia plunges 32% after CEO resignation.

Nasdaq enters correction amid rapid sell-off; Nvidia plunges 32% after CEO resignation.

The Nasdaq Composite has dropped over 13% from its all-time high, entering a correction phase, with the Dow and S&P 500 also down significantly. Nvidia's stock fell 32% in three weeks following the unexpected resignation of its CEO Jensen Huang, rais...

Bearish
1 hour ago
S&P 500 volatility rises post-midterms, signaling uncertain market ahead with mixed historical returns.

S&P 500 volatility rises post-midterms, signaling uncertain market ahead with mixed historical returns.

Since the midterm elections, the S&P 500 has experienced increased volatility, falling about 10% from its all-time high. Historical data shows mixed outcomes after similar swings, with recent years seeing positive returns but earlier periods marked b...

Market News
Neutral
1 hour ago
CAVA's rapid growth challenges Lululemon's strong profits in consumer stock race for 2027.

CAVA's rapid growth challenges Lululemon's strong profits in consumer stock race for 2027.

CAVA Group is expanding quickly in the Mediterranean fast-casual market, showing 27% revenue growth and steady restaurant efficiency, while Lululemon Athletica maintains high profitability with $11.1 billion revenue and strong free cash flow. CAVA ap...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App